Now livetag icon
Who's really winning the World Cup economy? The data is in!Get the snapshotbanner icon
VelaVigo

May 2026

VelaVigo Market Share Analysis for May 2026

Industry: N/A
Year Founded2021
Employees51 - 200
Annual Revenue--
velavigo.com
VelaVigo
VelaVigo (including company regionals)
  • velavigo.com
    velavigo.com
See more website traffic and engagement information

Total visits to VelaVigo's top domains

Understand VelaVigo market share and potential market reach.

Total visits last 3 months

No Data to Display

No Data to Display

Avg. visit duration in VelaVigo's top domains

Analyze VelaVigo engagement metrics.

Average visit duration last 3 months

No Data to Display

No Data to Display

Avg. pageviews on VelaVigo's top domains

See how VelaVigo keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

No Data to Display

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


VelaVigo top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by VelaVigo

These are the website technologies, by industry, used by VelaVigo top domains

Email Services (1)

Microsoft Exchange Online

Microsoft Exchange Online

Mobile (1)

Meta Viewport

Meta Viewport

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from VelaVigo

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVelaVigo Cayman Limited partnered with Avenzo Therapeutics, Inc. on Sep 2nd '25.VelaVigo announces exclusive option agreement with Avenzo to license A potential first-in-class Nectin4/TROP2 bispecific antibody-drug conjugate VelaVigo cayman limited (VelaVigo), a biotech company focusing on discovery and development of multi-specific antibodies and antibody-drug conjugates (ADC), today announced it has entered into an...
NewsVelaVigo Cayman Limited received financing of $60M in Pre-A+ financing on Jul 28th '25.VelaVigo announces over $60 million in Pre-A+ financing to accelerate global clinical development of first-in-class drug pipeline.

See all VelaVigo signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.